Table 4 (A) Median concentrations and ranges of individual biomarker candidates in serum and P values for comparison of clinical groups in all stages of the menstrual cycle. (B) Analysis by menstrual cycle phase showing significant differences in candidate biomarker levels. P values < 0.05 are considered significant

7.7 (1.3–28.0)

7.7 (0.6–273.0)

22.5 (0.70–386.6)

245 (18–2512)

419 (79–1616)

345 (18–2110)

1.9 (0.6–43.7)

6.1 (0.9–53.4)

2.3 (0.2–61.7)

301.4 (81.9–502.3)

265.7 (85.83–624.7)

342.1 (92.3–730.8)

12.72 (7.65–19.23)

11.33 (6.41–23.29)

12.35 (0.57–23.2)

0.32 (0.10–1.55)

0.26 (0.07–1.39)

0.27 (0.03–2.25)

24.81 (2.20–106.3)

30.87 (2.22–282.8)

24.11 (2.25–314.6)

0.33 (0.07–1.00)

0.32(0.09–0.95)

0.41 (0.15–1.41)

0.82 (0.27–3.79)

0.73 (0.28–2.41)

0.67 (0.23–4.33)

7.22 (1.03–51.82)

11.35 (4.92–38.84)

13.52 (0.70–79.68)

47.05 (0.60–101.1)

41.7 (0.18–111,3)

45.0 (6.39–133.0)

40.31 (11.27–152.2)

73.24 (13.47–154.7)

46.27 (7.09–182.4)

3.83 (0.4–70.75)

4.32(0.02–38.03)

6.13 (0.4–94.62)

0.7 (0.6–9.2)

0.6 (0.6–10.0)

0.75 (0.6–20.0)